Hyperactive CDK2 Activity in Basal-like Breast Cancer Imposes a Genome Integrity Liability that can be Exploited by Targeting DNA Polymerase Epsilon

Published: 27-10-2020| Version 1 | DOI: 10.17632/xvgb9rg7b7.1
Contributor:
Richard Possemato

Description

Data from "Hyperactive CDK2 Activity in Basal-like Breast Cancer Imposes a Genome Integrity Liability that can be Exploited by Targeting DNA Polymerase Epsilon"

Files